| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
|
Int J Cancer
|
1975
|
5.91
|
|
2
|
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
|
J Exp Med
|
1981
|
5.76
|
|
3
|
Natural cell-mediated immunity.
|
Adv Cancer Res
|
1978
|
5.53
|
|
4
|
Natural killer cells: their roles in defenses against disease.
|
Science
|
1981
|
4.59
|
|
5
|
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
|
Int J Cancer
|
1975
|
3.54
|
|
6
|
Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.
|
J Immunol
|
1977
|
3.52
|
|
7
|
Natural killer cells: characteristics and regulation of activity.
|
Immunol Rev
|
1979
|
3.14
|
|
8
|
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
|
J Immunol
|
1984
|
3.07
|
|
9
|
Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies.
|
J Immunol
|
1981
|
3.05
|
|
10
|
Augmentation of mouse natural killer cell activity by interferon and interferon inducers.
|
J Immunol
|
1979
|
2.80
|
|
11
|
A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity.
|
J Immunol
|
1977
|
2.60
|
|
12
|
Heterogeneity of natural killer cells.
|
Annu Rev Immunol
|
1984
|
2.59
|
|
13
|
Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
|
J Exp Med
|
1974
|
2.40
|
|
14
|
Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.
|
Int J Cancer
|
1977
|
2.39
|
|
15
|
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.
|
J Exp Med
|
1989
|
2.33
|
|
16
|
Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.
|
J Immunol
|
1981
|
2.12
|
|
17
|
Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
|
J Immunol
|
1986
|
2.05
|
|
18
|
Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
|
Cancer Res
|
1998
|
2.04
|
|
19
|
Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells.
|
J Immunol
|
1978
|
2.04
|
|
20
|
Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition.
|
J Exp Med
|
1976
|
2.01
|
|
21
|
Depletion of monocytes from human peripheral blood mononuclear leukocytes: comparison of the sephadex G-10 column method with other commonly used techniques.
|
J Immunol Methods
|
1980
|
1.92
|
|
22
|
Cytotoxic reactivity of human lymphocytes cultured in vitro.
|
J Immunol
|
1977
|
1.88
|
|
23
|
Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
|
Cancer Res
|
1989
|
1.84
|
|
24
|
Cytolytic and cytostatic activity on tumor cells of circulating human monocytes.
|
Int J Cancer
|
1979
|
1.84
|
|
25
|
T-cell homeostasis in HIV infection is neither failing nor blind: modified cell counts reflect an adaptive response of the host.
|
Nat Med
|
1997
|
1.82
|
|
26
|
Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses.
|
J Exp Med
|
1982
|
1.81
|
|
27
|
Interleukin 2 dependence of human natural killer (NK) cell activity.
|
J Immunol
|
1983
|
1.79
|
|
28
|
Chédiak-Higashi gene in humans I. Impairment of natural-killer function.
|
J Exp Med
|
1980
|
1.79
|
|
29
|
Mechanism of cytotoxicity by natural killer (NK) cells.
|
Annu Rev Immunol
|
1986
|
1.72
|
|
30
|
Breast conservation versus mastectomy: distress sequelae as a function of choice.
|
J Clin Oncol
|
1989
|
1.70
|
|
31
|
Inhibition of murine natural killer cell activity by prostaglandins.
|
J Immunol
|
1980
|
1.68
|
|
32
|
Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
|
J Immunol
|
1975
|
1.62
|
|
33
|
Cell-mediated immunity to tumor cells.
|
Adv Cancer Res
|
1974
|
1.60
|
|
34
|
Mastectomy versus breast conservation surgery: mental health effects at long-term follow-up.
|
Health Psychol
|
1992
|
1.56
|
|
35
|
Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.
|
J Immunol
|
1985
|
1.55
|
|
36
|
Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins.
|
Int J Cancer
|
1972
|
1.55
|
|
37
|
Fc receptors on mouse effector cells mediating natural cytotoxicity against tumor cells.
|
J Immunol
|
1977
|
1.53
|
|
38
|
Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.
|
J Immunol
|
1976
|
1.53
|
|
39
|
Natural killer (NK) cells and their possible roles in resistance against disease.
|
Clin Immunol Rev
|
1981
|
1.52
|
|
40
|
Cell-mediated cytotoxicity for bladder carcinoma: evaluation of a workshop.
|
Cancer Res
|
1975
|
1.51
|
|
41
|
Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry.
|
J Immunol
|
1981
|
1.51
|
|
42
|
Role of NK cells in the control of metastatic spread and growth of tumor cells in mice.
|
Int J Cancer
|
1982
|
1.50
|
|
43
|
Role of macrophages in the augementation of mouse natural killer cell activity by poly I:C and interferon.
|
J Immunol
|
1979
|
1.49
|
|
44
|
Identification and separation of Thy-1 positive mouse spleen cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity.
|
J Immunol
|
1979
|
1.48
|
|
45
|
Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
|
J Immunol
|
1999
|
1.48
|
|
46
|
Low affinity E-rosette formation by the human K cell.
|
J Immunol
|
1978
|
1.45
|
|
47
|
Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
|
Cancer Res
|
1990
|
1.45
|
|
48
|
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels.
|
Cancer Immunol Immunother
|
1992
|
1.45
|
|
49
|
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
|
Int J Cancer
|
1992
|
1.45
|
|
50
|
Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.
|
J Natl Cancer Inst
|
1973
|
1.45
|
|
51
|
Calculation of lytic units for the expression of cell-mediated cytotoxicity.
|
J Immunol Methods
|
1992
|
1.44
|
|
52
|
Natural cytotoxicity of mouse monocytes and macrophages.
|
J Immunol
|
1979
|
1.43
|
|
53
|
Natural cell-mediated cytotoxicity in mice against non-lymphoid tumor cells and some normal cells.
|
Int J Cancer
|
1977
|
1.42
|
|
54
|
Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.
|
Int J Cancer
|
1984
|
1.42
|
|
55
|
Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.
|
Genes Chromosomes Cancer
|
1991
|
1.42
|
|
56
|
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
|
J Exp Med
|
1984
|
1.41
|
|
57
|
Effect of ultraviolet irradiation on MCA102 tumor cell immunogenicity and sensitivity to tumor necrosis factor.
|
Cancer Res
|
1991
|
1.41
|
|
58
|
Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function.
|
J Exp Med
|
1980
|
1.41
|
|
59
|
Human T lymphocyte subpopulations: correlation between E-rosette-forming affinity and expression of the Fc receptor.
|
J Immunol
|
1977
|
1.39
|
|
60
|
Mediation of mouse natural cytotoxic activity by tumour necrosis factor.
|
Nature
|
1986
|
1.39
|
|
61
|
Isolation of human and rat natural killer cells.
|
J Immunol Methods
|
1982
|
1.39
|
|
62
|
Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells.
|
Proc Natl Acad Sci U S A
|
1981
|
1.39
|
|
63
|
Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
|
J Natl Cancer Inst
|
1974
|
1.38
|
|
64
|
Natural cell-mediated cytotoxicity in rats. II. In vivo augmentation of NK-cell activity.
|
Int J Cancer
|
1978
|
1.38
|
|
65
|
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
|
J Immunol
|
1986
|
1.37
|
|
66
|
Natural cell-mediated cytotoxicity in rats. III. Effects of immunopharmacologic treatments on natural reactivity and on reactivity augmented by polyinosinic-polycytidylic acid.
|
Int J Cancer
|
1978
|
1.37
|
|
67
|
Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays.
|
J Natl Cancer Inst
|
1974
|
1.36
|
|
68
|
Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line.
|
J Natl Cancer Inst
|
1977
|
1.36
|
|
69
|
Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity.
|
J Immunol
|
1982
|
1.34
|
|
70
|
Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.
|
J Clin Lab Anal
|
1990
|
1.32
|
|
71
|
Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity.
|
J Immunol
|
1979
|
1.32
|
|
72
|
The role of natural killer cells in immune surveillance of cancer.
|
Curr Opin Immunol
|
1995
|
1.32
|
|
73
|
Wild-type gross leukemia virus: classification of soluble antigens (GSA).
|
J Virol
|
1972
|
1.31
|
|
74
|
Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.
|
Clin Exp Immunol
|
1971
|
1.31
|
|
75
|
An isotopic antiglobulin technique for measuring antibodies to cell-surface antigens.
|
J Immunol
|
1969
|
1.31
|
|
76
|
Natural cytotoxicity of mouse, rat, and human lymphocytes against heterologous target cells.
|
J Natl Cancer Inst
|
1979
|
1.30
|
|
77
|
Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
|
J Natl Cancer Inst
|
1972
|
1.29
|
|
78
|
Selective depletion of human natural killer cells on monolayers of target cells.
|
J Immunol
|
1980
|
1.29
|
|
79
|
Cutaneous hypersensitivity reactions to autologous extracts of malignant melanoma cells.
|
Lancet
|
1970
|
1.27
|
|
80
|
Rapid in vivo assay of mouse natural killer cell activity.
|
J Natl Cancer Inst
|
1979
|
1.26
|
|
81
|
In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats.
|
J Immunol
|
1983
|
1.26
|
|
82
|
Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.
|
J Immunol
|
1983
|
1.25
|
|
83
|
Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt-lymphoma cells.
|
N Engl J Med
|
1970
|
1.25
|
|
84
|
Immune reactivity of leukemia patients to autologous blast cells.
|
Cancer Res
|
1972
|
1.24
|
|
85
|
A species of human alpha interferon that lacks the ability to boost human natural killer activity.
|
Proc Natl Acad Sci U S A
|
1984
|
1.23
|
|
86
|
Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages.
|
J Leukoc Biol
|
1985
|
1.23
|
|
87
|
Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo.
|
J Exp Med
|
1980
|
1.23
|
|
88
|
Natural killer cells as antitumor effector cells.
|
J Natl Cancer Inst
|
1979
|
1.21
|
|
89
|
Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation.
|
J Natl Cancer Inst
|
1991
|
1.20
|
|
90
|
Cytotoxic effector cells with the characteristics of natural killer cells in the lungs of mice.
|
Int J Cancer
|
1980
|
1.20
|
|
91
|
Role of human natural killer cells in health and disease.
|
Clin Diagn Lab Immunol
|
1994
|
1.19
|
|
92
|
Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.
|
J Natl Cancer Inst
|
1972
|
1.19
|
|
93
|
Functional activities of rosette separated human peripheral blood leukocytes.
|
J Immunol
|
1975
|
1.19
|
|
94
|
Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
|
J Immunol
|
1989
|
1.19
|
|
95
|
Human large granular lymphocytes are potent producers of interleukin-1.
|
Nature
|
1984
|
1.18
|
|
96
|
Natural killer cells and tumor therapy.
|
Curr Top Microbiol Immunol
|
1998
|
1.18
|
|
97
|
Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
|
J Immunol
|
1987
|
1.17
|
|
98
|
Augmentation of human monocyte-mediated cytolysis by interferon.
|
Cell Immunol
|
1980
|
1.17
|
|
99
|
Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
|
J Immunol
|
1985
|
1.17
|
|
100
|
In vivo natural reactivity of mice against tumor cells.
|
Int J Cancer
|
1980
|
1.16
|
|
101
|
Expression of fetal antigens in tumor cells.
|
Proc Natl Acad Sci U S A
|
1972
|
1.16
|
|
102
|
Delayed-hypersensitivity reactions to soluble membrane antigens of human malignant lung cells.
|
J Natl Cancer Inst
|
1974
|
1.16
|
|
103
|
Inhibition of the mixed lymphocyte culture by peritoneal exudate cells.
|
Cell Immunol
|
1976
|
1.15
|
|
104
|
Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.
|
Blood
|
1998
|
1.15
|
|
105
|
Analysis of T cell receptors in highly purified rat and human large granular lymphocytes (LGL): lack of functional 1.3 kb beta-chain mRNA.
|
J Immunol
|
1986
|
1.14
|
|
106
|
Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer.
|
Behav Med
|
1991
|
1.14
|
|
107
|
Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. II. Evidenceth Kilham rat virus is responsible for the inhibitory effect.
|
Cell Immunol
|
1977
|
1.13
|
|
108
|
Cell-mediated immunity to retinal antigens in patients with pigmentary retinal degenerations.
|
Invest Ophthalmol
|
1974
|
1.13
|
|
109
|
Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
|
Blood
|
1998
|
1.13
|
|
110
|
Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
|
J Immunol
|
1985
|
1.13
|
|
111
|
Cytotoxic activities of normal cultured human T cells.
|
J Immunol
|
1978
|
1.12
|
|
112
|
Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity.
|
J Immunol
|
1980
|
1.12
|
|
113
|
Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes.
|
Int J Cancer
|
1983
|
1.12
|
|
114
|
Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients.
|
Psychosom Med
|
1990
|
1.11
|
|
115
|
Interferon activates macrophages to produce plasminogen activator.
|
J Interferon Res
|
1982
|
1.11
|
|
116
|
Immune and natural antibodies to syngeneic murine plasma cell tumors.
|
J Exp Med
|
1972
|
1.11
|
|
117
|
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.
|
Cancer Res
|
1988
|
1.10
|
|
118
|
In vitro human reactivity to staphylococcal phage lysate.
|
J Immunol
|
1975
|
1.09
|
|
119
|
Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
|
J Natl Cancer Inst
|
1975
|
1.09
|
|
120
|
The suppression of mitogen- and alloantigen-stimulated peripheral blood lymphocytes by cultured human T lymphocytes.
|
J Immunol
|
1979
|
1.09
|
|
121
|
Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response.
|
J Natl Cancer Inst
|
1971
|
1.09
|
|
122
|
Isolation, phenotyping, and functional analysis of lymphocytes from human liver.
|
Clin Immunol Immunopathol
|
1990
|
1.09
|
|
123
|
Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.
|
Cell Immunol
|
1991
|
1.09
|
|
124
|
Natural cell-mediated cytotoxicity in rats. I. Tissue and strain distribution, and demonstration of a membrance receptor for the Fc portion of IgG.
|
Int J Cancer
|
1978
|
1.08
|
|
125
|
Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes.
|
Cell Immunol
|
1982
|
1.08
|
|
126
|
Comparison of toxicity and survival following intraperitoneal recombinant interleukin-2 for persistent ovarian cancer after platinum: twenty-four-hour versus 7-day infusion.
|
J Clin Oncol
|
1997
|
1.08
|
|
127
|
Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity.
|
Blood
|
1980
|
1.08
|
|
128
|
Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines.
|
J Exp Med
|
1985
|
1.07
|
|
129
|
Inhibition of rat mixed lymphocyte cultures by suppressor macrophages.
|
Cell Immunol
|
1977
|
1.07
|
|
130
|
In vivo reactivity of mouse natural killer (NK) cells against normal bone marrow cells.
|
Cell Immunol
|
1981
|
1.06
|
|
131
|
Natural killer cell activity in the rat. Analysis of effector cell morphology and effects of interferon on natural killer cell function in the athymic (nude) rat.
|
Eur J Immunol
|
1982
|
1.06
|
|
132
|
Inhibition of human natural killer cell activity by cytophilic immunoglobulin G.
|
J Immunol
|
1982
|
1.05
|
|
133
|
Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors.
|
Int J Cancer
|
1975
|
1.05
|
|
134
|
Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays.
|
J Natl Cancer Inst
|
1975
|
1.04
|
|
135
|
Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity.
|
Nat Immun Cell Growth Regul
|
1991
|
1.04
|
|
136
|
Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas.
|
J Natl Cancer Inst
|
1980
|
1.03
|
|
137
|
Immune response to Gross virus-induced lymphoma. II. Kinetics of the cellular immune response.
|
J Natl Cancer Inst
|
1971
|
1.03
|
|
138
|
Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human breast carcinoma.
|
J Natl Cancer Inst
|
1974
|
1.02
|
|
139
|
Natural killer cell reactivity: regulatory interactions and among phorbol ester, interferon, cholera toxin, and retinoic acid.
|
J Immunol
|
1981
|
1.02
|
|
140
|
Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2.
|
Cancer
|
1989
|
1.02
|
|
141
|
Cutaneous delayed hypersensitivity responses of patients with retinoblastoma to standard recall antigens and crude membrane extracts of retino-blastoma tissue culture cells.
|
Am J Ophthalmol
|
1974
|
1.01
|
|
142
|
A phase I trial of recombinant gamma interferon in patients with cancer.
|
Cancer Immunol Immunother
|
1985
|
1.01
|
|
143
|
Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
|
Cell Immunol
|
1993
|
1.01
|
|
144
|
The circulating lymphocyte--its role in infectious mononucleosis.
|
Ann Intern Med
|
1968
|
1.01
|
|
145
|
Natural killer activity of human liver-derived lymphocytes in various liver diseases.
|
Hepatology
|
1991
|
1.01
|
|
146
|
Isolation and identification of soluble skin-reactive membrane antigens of malignant and normal human breast cells.
|
Cancer Res
|
1974
|
1.00
|
|
147
|
Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors.
|
J Immunol
|
1981
|
1.00
|
|
148
|
In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
|
J Natl Cancer Inst
|
1973
|
1.00
|
|
149
|
Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.
|
J Immunol
|
1979
|
1.00
|
|
150
|
In vitro activation of cellular immune response to Gross virus-induced lymphoma.
|
J Exp Med
|
1972
|
1.00
|
|
151
|
Relationship between T lymphocyte levels and lymphoproliferative responses to mitogens and alloantigens in lung and breast cancer patients.
|
Int J Cancer
|
1978
|
1.00
|
|
152
|
51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells.
|
Natl Cancer Inst Monogr
|
1973
|
0.99
|
|
153
|
Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients.
|
J Natl Cancer Inst
|
1978
|
0.99
|
|
154
|
Immunogenicity of tumor antigens.
|
Biochim Biophys Acta
|
1977
|
0.98
|
|
155
|
Natural killer cells and their possible relevance to transplantation biology.
|
Transplantation
|
1982
|
0.98
|
|
156
|
Cultures of purified human natural killer cells: growth in the presence of interleukin 2.
|
Cell Immunol
|
1982
|
0.98
|
|
157
|
Natural cytotoxic reactivity of rat lymphocytes against syngeneic Gross virus-induced lymphoma.
|
J Natl Cancer Inst
|
1976
|
0.98
|
|
158
|
Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters.
|
Health Psychol
|
1985
|
0.98
|
|
159
|
Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases.
|
Clin Immunol Immunopathol
|
1976
|
0.98
|
|
160
|
Modulation of fetal antigen(s) in mouse leukemia cells.
|
Cancer Res
|
1974
|
0.98
|
|
161
|
Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.
|
J Exp Med
|
1988
|
0.98
|
|
162
|
Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon.
|
J Immunol
|
1983
|
0.97
|
|
163
|
Nonsecretory apoptotic killing by human NK cells.
|
J Immunol
|
1996
|
0.97
|
|
164
|
Cell-mediated immunity to a retinoblastoma tissue culture line in patients with retinoblastoma.
|
Am J Ophthalmol
|
1974
|
0.97
|
|
165
|
Immunological monitoring and immunotherapy in carcinoma of the lung.
|
Int J Cancer
|
1976
|
0.97
|
|
166
|
Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL).
|
J Immunol
|
1986
|
0.97
|
|
167
|
Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer.
|
J Natl Cancer Inst
|
1977
|
0.97
|
|
168
|
Purification and characterization of a human lung tumor-associated antigen.
|
J Natl Cancer Inst
|
1978
|
0.97
|
|
169
|
H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
|
J Immunol
|
1988
|
0.96
|
|
170
|
Expression and function of CD7 molecule on human natural killer cells.
|
J Immunol
|
1994
|
0.96
|
|
171
|
Potent activation of mouse macrophages by recombinant interferon-gamma.
|
Cancer Res
|
1984
|
0.96
|
|
172
|
Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
|
Cancer Treat Rep
|
1978
|
0.96
|
|
173
|
Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia.
|
Int J Cancer
|
1973
|
0.96
|
|
174
|
Cytostasis of tumor cell lines by human granulocytes.
|
Cell Immunol
|
1980
|
0.96
|
|
175
|
Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes.
|
Cell Immunol
|
1986
|
0.96
|
|
176
|
The role of natural killer cells in human disease.
|
Clin Immunol Immunopathol
|
1989
|
0.96
|
|
177
|
Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors.
|
Cell Immunol
|
1974
|
0.96
|
|
178
|
Macrophages as regulators of immune responses against tumors.
|
Adv Exp Med Biol
|
1979
|
0.96
|
|
179
|
A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses.
|
Eur J Cancer Clin Oncol
|
1982
|
0.96
|
|
180
|
Propagation of mouse cytotoxic clones with characteristics of natural killer (NK) cells.
|
Cell Immunol
|
1982
|
0.95
|
|
181
|
Immunologic approaches to the diagnosis of cancer.
|
Cancer
|
1976
|
0.95
|
|
182
|
Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.
|
Hepatology
|
1992
|
0.95
|
|
183
|
Evaluation of the effect of remission plasma on untreated patients with Burkitt's lymphoma.
|
J Natl Cancer Inst
|
1970
|
0.95
|
|
184
|
Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases.
|
J Exp Med
|
1991
|
0.95
|
|
185
|
Cryopreservation of human lymphocyte function as measured by in vitro assays.
|
Int J Cancer
|
1976
|
0.95
|
|
186
|
Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells.
|
Natl Cancer Inst Monogr
|
1973
|
0.95
|
|
187
|
Ig-binding receptors on human NK cells as effector and regulatory surface molecules.
|
Int Rev Immunol
|
2001
|
0.95
|
|
188
|
In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells.
|
Cell Immunol
|
1988
|
0.94
|
|
189
|
Immunoregulation and natural killer cells.
|
Mol Immunol
|
1982
|
0.94
|
|
190
|
Augmentation of metastasis formation by thioglycollate-elicited macrophages.
|
Int J Cancer
|
1982
|
0.94
|
|
191
|
Augmentation of tumoricidal activity of human monocytes and macrophages by lymphokines.
|
Int J Cancer
|
1980
|
0.94
|
|
192
|
Changes of liver-resident NK cells during liver regeneration in rats.
|
J Immunol
|
1995
|
0.94
|
|
193
|
A human lymphoid cell line with receptors for both sheep red blood cells and complement.
|
Cell Immunol
|
1974
|
0.94
|
|
194
|
Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
|
J Immunol
|
1987
|
0.94
|
|
195
|
Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions.
|
J Immunol
|
1985
|
0.93
|
|
196
|
In vitro augmentation of rat natural killer (NK) cell activity.
|
J Immunol
|
1981
|
0.93
|
|
197
|
The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens.
|
Int J Cancer
|
1977
|
0.93
|
|
198
|
Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
|
J Immunol
|
1994
|
0.93
|
|
199
|
Effects of adriamycin on the activity of mouse natural killer cells.
|
J Immunol
|
1980
|
0.93
|
|
200
|
Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
|
Cancer Res
|
1993
|
0.93
|
|
201
|
Adhesion characteristics of human interleukin 2-activated natural killer cells.
|
Cell Immunol
|
1991
|
0.93
|
|
202
|
Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
|
J Immunol
|
1987
|
0.93
|
|
203
|
Cytotoxicity inhibition assay: cryopreservation and standardization: brief communication.
|
J Natl Cancer Inst
|
1977
|
0.92
|
|
204
|
Modulation of IL 2-dependent growth of mouse NK cells by interferon and T lymphocytes.
|
J Immunol
|
1983
|
0.92
|
|
205
|
The current status of human monocyte-mediated cytotoxicity against tumor cells.
|
J Leukoc Biol
|
1985
|
0.92
|
|
206
|
Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells.
|
J Natl Cancer Inst
|
1977
|
0.92
|
|
207
|
Inhibition of human natural killer cell reactivity by exogenous adenosine 5'-triphosphate.
|
J Immunol
|
1984
|
0.92
|
|
208
|
From HIV infection to AIDS: are the manifestations of effective immune resistance misinterpreted?
|
Clin Immunol Immunopathol
|
1993
|
0.92
|
|
209
|
A cytotoxic antiglobulin technique for assay of antibodies to histocompatibility antigens.
|
J Immunol
|
1969
|
0.92
|
|
210
|
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
|
Cancer Res
|
1992
|
0.92
|
|
211
|
Spontaneous cytotoxicity by monocyte-enriched subpopulations of human peripheral blood mononuclear cells against human or mouse anchorage-dependent tumour cell lines. Contribution of NK-like cells.
|
Scand J Immunol
|
1983
|
0.91
|
|
212
|
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
|
Cancer Res
|
1989
|
0.91
|
|
213
|
Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
|
Surg Gynecol Obstet
|
1975
|
0.91
|
|
214
|
Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines.
|
J Immunol
|
1981
|
0.91
|
|
215
|
Inverse relationship of polyoma tumour specific cell surface antigen to H-2 histocompatibility antigens.
|
Nat New Biol
|
1971
|
0.91
|
|
216
|
Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production.
|
J Immunol
|
1978
|
0.91
|
|
217
|
Induction of tumor regression in experimental model of human head and neck cancer by human A-LAK cells and IL-2.
|
Int J Cancer
|
1991
|
0.91
|
|
218
|
Conditions for generating and assaying human leukocyte inhibitory factor (LIF) induced by purified protein derivative (PPD).
|
Immunopharmacology
|
1978
|
0.91
|
|
219
|
Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
|
Cancer Res
|
1987
|
0.91
|
|
220
|
Production of multiple cytokines by clones of human large granular lymphocytes.
|
Cancer Immunol Immunother
|
1985
|
0.91
|
|
221
|
Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
|
J Immunol
|
1992
|
0.91
|
|
222
|
Cellular microcytotoxicity in human tumor systems: analysis of results.
|
J Natl Cancer Inst
|
1975
|
0.91
|
|
223
|
Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents.
|
Cancer Immunol Immunother
|
1985
|
0.91
|
|
224
|
Therapeutic activity of NK cells against tumors.
|
Int Rev Immunol
|
2001
|
0.90
|
|
225
|
Inhibition of human natural killer (NK) activity and antibody dependent cellular cytotoxicity (ADCC) by lipomodulin, a phospholipase inhibitory protein.
|
J Immunol
|
1983
|
0.90
|
|
226
|
Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.
|
Cell Immunol
|
1993
|
0.90
|
|
227
|
Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
|
J Immunol
|
1986
|
0.90
|
|
228
|
Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
|
J Immunol
|
1976
|
0.90
|
|
229
|
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.
|
Cancer Res
|
1994
|
0.90
|
|
230
|
Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion.
|
J Immunol
|
1993
|
0.90
|
|
231
|
Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages.
|
Ann N Y Acad Sci
|
1980
|
0.89
|
|
232
|
Direct comparison of three isotopic release microtoxicity assays as measures of cell-mediated immunity to Gross virus-induced lymphomas in rats.
|
J Natl Cancer Inst
|
1977
|
0.89
|
|
233
|
The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
|
Cancer Res
|
1992
|
0.89
|
|
234
|
Production of both macrophage activating and inhibiting activities by a murine T-lymphocyte hybridoma.
|
Nature
|
1981
|
0.89
|
|
235
|
Suppression of activity of mouse natural killer (NK) cells by activated macrophages from mice treated with pyran copolymer.
|
Int J Cancer
|
1980
|
0.89
|
|
236
|
Dysfunction of natural killer activity in a family with chronic fatigue syndrome.
|
Clin Immunol Immunopathol
|
1998
|
0.89
|
|
237
|
Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck.
|
Int J Cancer
|
1993
|
0.89
|
|
238
|
Lymphoproliferative responses to autologous tumor extracts as prognostic indicators in patients with resected breast cancer.
|
Int J Cancer
|
1981
|
0.89
|
|
239
|
Methionine enkephalin: a new cytokine--human studies.
|
Clin Immunol Immunopathol
|
1997
|
0.89
|
|
240
|
Tumor markers in cancer diagnosis and prognosis.
|
CA Cancer J Clin
|
1988
|
0.89
|
|
241
|
The effect of immunopharmacological agents on mouse natural cell-mediated cytotoxicity and on its augmentation by poly I:C.
|
Immunopharmacology
|
1979
|
0.89
|
|
242
|
Studies on the specificity of human cytotoxic antibody reactive with cultures of lymphoid cells.
|
J Natl Cancer Inst
|
1969
|
0.89
|
|
243
|
Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.
|
J Leukoc Biol
|
1990
|
0.88
|
|
244
|
Role of natural killer activity in development of spontaneous metastases in murine renal cancer.
|
J Urol
|
1985
|
0.88
|
|
245
|
Effect of rhinovirus 39 infection on cellular immune parameters in allergic and nonallergic subjects.
|
J Allergy Clin Immunol
|
1993
|
0.88
|
|
246
|
Detection of decreased proportion of lymphocytes forming rosettes with sheep erythrocytes at 29 degrees C in the blood of cancer patients. Analysis of factors affecting the assay.
|
Clin Immunol Immunopathol
|
1977
|
0.88
|
|
247
|
An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
|
J Natl Cancer Inst
|
1973
|
0.88
|
|
248
|
Cytolytic activity of circulating human monocytes on transformed and untransformed human fibroblasts.
|
Int J Cancer
|
1979
|
0.88
|
|
249
|
Association of depressed postoperative lymphoproliferative responses to alloantigens with poor prognosis in patients with stage I lung cancer.
|
Int J Cancer
|
1980
|
0.88
|
|
250
|
Low deformability of lymphokine-activated killer cells as a possible determinant of in vivo distribution.
|
Cancer Res
|
1989
|
0.88
|
|
251
|
Natural killer activity in the rat. IV. Distribution of large granular lymphocytes (LGL) following intravenous and intraperitoneal transfer.
|
Cell Immunol
|
1984
|
0.88
|
|
252
|
Augmentation of human K-cell activity with interferon.
|
Scand J Immunol
|
1980
|
0.88
|
|
253
|
Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice.
|
J Natl Cancer Inst
|
1975
|
0.88
|
|
254
|
Detection of tumor-specific cell surface antigen of simian virus 40-induced tumors by the isotopic antiglobulin technique.
|
Int J Cancer
|
1971
|
0.88
|
|
255
|
Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
|
Cancer Res
|
1991
|
0.87
|
|
256
|
Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
|
Cancer Res
|
1978
|
0.87
|
|
257
|
Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.
|
Crit Rev Oncol Hematol
|
1992
|
0.87
|
|
258
|
Characterization by monoclonal antibodies of the cytotoxic effector cells in human peripheral blood mononuclear cells reactive against anchorage-dependent tumour cell lines.
|
Scand J Immunol
|
1983
|
0.87
|
|
259
|
Extravasation of antitumor effector cells.
|
Invasion Metastasis
|
1992
|
0.87
|
|
260
|
Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
|
Cancer Res
|
1988
|
0.87
|
|
261
|
Persistently low natural killer cell activity in normal adults: immunological, hormonal and mood correlates.
|
Nat Immun Cell Growth Regul
|
1989
|
0.87
|
|
262
|
Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.
|
Nat Immun Cell Growth Regul
|
1990
|
0.87
|
|
263
|
Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
|
J Immunol
|
1995
|
0.87
|
|
264
|
Natural killer cells.
|
Annu Rev Med
|
1986
|
0.87
|
|
265
|
Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
|
Int J Cancer
|
1990
|
0.87
|
|
266
|
Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
|
J Immunol
|
1978
|
0.87
|
|
267
|
Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. I. Characteristics of inhibition and evidence for an infectious agent.
|
Cell Immunol
|
1977
|
0.87
|
|
268
|
Expression of various tumor-specific antigens in polyoma virus-induced tumors.
|
Cancer Res
|
1972
|
0.87
|
|
269
|
Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.
|
J Immunol
|
1975
|
0.87
|
|
270
|
Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. II. Regulatory role of interferon on proliferative and cytotoxic precursors.
|
J Immunol
|
1983
|
0.87
|
|
271
|
Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
|
Cancer Res
|
1993
|
0.86
|
|
272
|
Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation.
|
J Immunol
|
1995
|
0.86
|
|
273
|
Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity.
|
J Natl Cancer Inst
|
1982
|
0.86
|
|
274
|
Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin 2.
|
Cancer Immunol Immunother
|
1986
|
0.86
|
|
275
|
A phase I evaluation of poly(I,C)-LC in cancer patients.
|
J Biol Response Mod
|
1985
|
0.86
|
|
276
|
Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission.
|
Blood
|
1988
|
0.86
|
|
277
|
Humoral host defense mechanisms against tumors.
|
Int Rev Exp Pathol
|
1976
|
0.86
|
|
278
|
Soluble membrane antigens of human malignant melanoma cells.
|
Cancer
|
1974
|
0.86
|
|
279
|
Delayed cutaneous sensitivity reactions to autologous Burkitt lymphoma protein extract. Results of a prospective two and a half year study.
|
Clin Exp Immunol
|
1971
|
0.86
|
|
280
|
Abrogation of the proliferation of human leukemia cells in nude mice by a xenoantiserum.
|
Leuk Res
|
1979
|
0.86
|
|
281
|
Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity.
|
J Natl Cancer Inst
|
1973
|
0.86
|
|
282
|
Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes.
|
Cell Immunol
|
1985
|
0.86
|
|
283
|
Production of plasminogen activator by human natural killer cells. Large granular lymphocytes.
|
J Exp Med
|
1984
|
0.86
|
|
284
|
In vitro inhibition of lymphoproliferative responses to tumor associated antigens and of lymphoma cell proliferation by rat splenic macrophages.
|
Cell Immunol
|
1977
|
0.85
|
|
285
|
Inhibition of natural cytotoxic rabbit antibody by human IgM: production of nontoxic rabbit serum for use as complement source.
|
J Immunol
|
1970
|
0.85
|
|
286
|
Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
|
J Immunol
|
1988
|
0.85
|
|
287
|
Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
|
Cancer Res
|
1988
|
0.85
|
|
288
|
Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
|
Cancer Immunol Immunother
|
1991
|
0.85
|
|
289
|
Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. I. Distribution of the reactivity.
|
J Natl Cancer Inst
|
1979
|
0.85
|
|
290
|
Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: comparison with the capillary tube assay.
|
J Immunol Methods
|
1977
|
0.85
|
|
291
|
Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
|
Cancer Immunol Immunother
|
1983
|
0.85
|
|
292
|
Studies of human natural killer cytotoxic factor (NKCF): characterization and analysis of its mode of action.
|
Adv Exp Med Biol
|
1985
|
0.85
|
|
293
|
Natural killer cells and gene therapy: potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases.
|
Nat Immun
|
1994
|
0.85
|
|
294
|
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine.
|
Cancer Res
|
1985
|
0.85
|
|
295
|
Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2.
|
Cancer Immunol Immunother
|
1988
|
0.85
|
|
296
|
Cryopreservation of human mononuclear cells for quality control in clinical immunology. I. Correlations in recovery of K- and NK-cell functions, surface markers, and morphology.
|
J Clin Immunol
|
1982
|
0.84
|
|
297
|
Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
|
Cancer Res
|
1990
|
0.84
|
|
298
|
Detection of humoral antibody response to polyoma tumor-specific cell-surface antigen.
|
J Natl Cancer Inst
|
1970
|
0.84
|
|
299
|
Beta1 integrin-mediated activation of focal adhesion kinase and its association with Fyn and Zap-70 in human NK cells.
|
J Immunol
|
1996
|
0.84
|
|
300
|
Studies on lymphokine activated killer cells in the rat: analysis of precursor and effector cell phenotype and relationship to natural killer cells.
|
Prog Clin Biol Res
|
1987
|
0.84
|
|
301
|
Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells.
|
J Natl Cancer Inst
|
1991
|
0.84
|
|
302
|
Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma.
|
J Immunol
|
1984
|
0.84
|
|
303
|
Serological analysis of immune response to friend virus-induced leukemia.
|
Cancer Res
|
1974
|
0.84
|
|
304
|
Immunogenicity of tumor antigens.
|
Ann N Y Acad Sci
|
1976
|
0.84
|
|
305
|
Effect of monoclonal antibodies (MoAb) to class I and class II HLA antigens on lectin- and MoAb OKT3-induced lymphocyte proliferation.
|
Cell Immunol
|
1985
|
0.84
|
|
306
|
Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells.
|
J Immunol
|
1984
|
0.84
|
|
307
|
Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.
|
Int J Cancer
|
1992
|
0.84
|
|
308
|
Cell-mediated immunity to melanoma-associated antigens in patients with ocular malignant melanoma.
|
Am J Ophthalmol
|
1975
|
0.84
|
|
309
|
Relationship of mouse natural killer cells to mouse natural cytotoxic cells: effector cells and possible mechanism of action.
|
Immunol Res
|
1986
|
0.84
|
|
310
|
In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
|
Cancer Res
|
1988
|
0.83
|
|
311
|
A review of data, problems, and open questions pertaining to in situ tumor immunity.
|
Contemp Top Immunobiol
|
1980
|
0.83
|
|
312
|
Role of NK cells in the antimetastatic effect of anticoagulant drugs.
|
Int J Cancer
|
1984
|
0.83
|
|
313
|
Physical and functional association of Fc mu receptor on human natural killer cells with the zeta- and Fc epsilon RI gamma-chains and with src family protein tyrosine kinases.
|
J Immunol
|
1996
|
0.83
|
|
314
|
Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity.
|
J Immunol
|
1985
|
0.83
|
|
315
|
Location by immunoelectron microscopy of carcinoembryonic antigen on cultured adenocarcinoma cells.
|
J Natl Cancer Inst
|
1975
|
0.83
|
|
316
|
Enzyme-linked immunosorbent assay for screening monoclonal antibody production: use of intact cells as antigen.
|
J Immunol Methods
|
1980
|
0.83
|
|
317
|
The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures.
|
J Exp Med
|
1990
|
0.83
|
|
318
|
Secondary cell-mediated cytotoxic response to syngeneic mouse tumor challenge.
|
J Immunol
|
1975
|
0.83
|
|
319
|
Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors.
|
Leuk Res
|
1987
|
0.83
|
|
320
|
Estrogen and antiestrogen modulation of the levels of mouse natural killer activity and large granular lymphocytes.
|
Cell Immunol
|
1987
|
0.83
|
|
321
|
Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells.
|
AIDS Res Hum Retroviruses
|
1990
|
0.83
|
|
322
|
Evaluation of the role of IgG antibodies in human natural cell-mediated cytotoxicity against the myeloid cell line K562.
|
J Immunol
|
1979
|
0.83
|
|
323
|
Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
|
J Immunol
|
1993
|
0.83
|
|
324
|
Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma.
|
N Engl J Med
|
1974
|
0.83
|
|
325
|
Regulation of human natural cytotoxicity by IgG--I. Characterization of the structural site on monomeric IgG responsible for inhibiting natural killer cell activity.
|
Mol Immunol
|
1987
|
0.83
|
|
326
|
Immunomodulatory effects of poly(I,C)-LC in cancer patients.
|
J Biol Response Mod
|
1985
|
0.83
|
|
327
|
Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
|
Cancer
|
1978
|
0.83
|
|
328
|
The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
|
Cancer Treat Rep
|
1986
|
0.83
|
|
329
|
Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
|
J Immunol
|
1993
|
0.83
|
|
330
|
Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon.
|
J Clin Immunol
|
1981
|
0.83
|
|
331
|
Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity.
|
J Leukoc Biol
|
1987
|
0.83
|
|
332
|
Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
|
Cancer Res
|
1975
|
0.83
|
|
333
|
Natural killer cells and their possible roles in host resistance against tumors.
|
Transplant Proc
|
1984
|
0.82
|
|
334
|
Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. II. Tumor transplantation studies.
|
Int J Cancer
|
1973
|
0.82
|
|
335
|
Heterogeneity of human natural killer cells.
|
J Natl Cancer Inst
|
1985
|
0.82
|
|
336
|
Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers.
|
Cancer Immunol Immunother
|
1985
|
0.82
|
|
337
|
Suppressor cells in tumor bearing mice and rats.
|
Biomedicine
|
1976
|
0.82
|
|
338
|
Rapidly progressing breast cancer (poussée évolutive) in Tunisia: studies on delayed hypersensitivity.
|
Int J Cancer
|
1978
|
0.82
|
|
339
|
Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution.
|
J Immunol
|
1988
|
0.82
|
|
340
|
Prolonged survival of tumor allografts in mice pretreated with soluble transplantation antigens.
|
J Natl Cancer Inst
|
1973
|
0.82
|
|
341
|
Divergent effects of Fc gamma RIIIA ligands on the functional activities of human natural killer cells in vitro.
|
Eur J Immunol
|
1996
|
0.82
|
|
342
|
Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay.
|
J Immunol Methods
|
1978
|
0.82
|
|
343
|
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.
|
Transplant Proc
|
1991
|
0.82
|
|
344
|
Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells.
|
Cell Immunol
|
1996
|
0.82
|
|
345
|
Immunologic tests in diagnosis of cancer.
|
Am J Clin Pathol
|
1977
|
0.82
|
|
346
|
The effect of lentinan on production of interleukin-1 by human monocytes.
|
Immunopharmacology
|
1982
|
0.82
|
|
347
|
Functional heterogeneity between NKR-P1bright/Lycopersicon esculentum lectin (L.E.)bright and NKR-P1bright/L.E.dim subpopulations of rat natural killer cells.
|
J Immunol
|
1992
|
0.82
|
|
348
|
Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors.
|
Int J Cancer
|
1981
|
0.82
|
|
349
|
Carcinoma of the lung: immunotherapy with intradermal BCG and allogeneic tumor cells.
|
Int J Radiat Oncol Biol Phys
|
1980
|
0.82
|
|
350
|
Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon.
|
Cell Immunol
|
1981
|
0.82
|
|
351
|
Antibody-induced augmentation of murine natural killer cell activity.
|
Int J Cancer
|
1981
|
0.82
|
|
352
|
Immune response to Gross virus-induced lymphoma: cryopreservation of functional activity of rat lymphocytes and tumor cells.
|
Cell Immunol
|
1976
|
0.82
|
|
353
|
Cytotoxic antibody in Burkitt's tumor and normal human serum reactive with cultures of lymphoid cells.
|
Proc Soc Exp Biol Med
|
1968
|
0.82
|
|
354
|
Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
|
Int J Cancer
|
1986
|
0.82
|
|
355
|
Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity.
|
J Natl Cancer Inst
|
1981
|
0.82
|
|
356
|
Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer patients propagated in culture with T cell growth factor (TCGF).
|
Eur J Cancer Clin Oncol
|
1983
|
0.82
|
|
357
|
Cell-mediated immunity to Friend virus-induced leukemia.
|
Cancer Res
|
1974
|
0.82
|
|
358
|
Low NK syndrome and its relationship to chronic fatigue syndrome.
|
Clin Immunol Immunopathol
|
1993
|
0.82
|
|
359
|
Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma.
|
Exp Hematol
|
1999
|
0.81
|
|
360
|
Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes.
|
Transplant Proc
|
1988
|
0.81
|
|
361
|
Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
|
J Natl Cancer Inst
|
1978
|
0.81
|
|
362
|
Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. I. Basic parameters: baseline controls, target cells, and methods of calculation.
|
J Natl Cancer Inst
|
1977
|
0.81
|
|
363
|
Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon.
|
Cancer Biother Radiopharm
|
1998
|
0.81
|
|
364
|
Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. I. Serological analysis of the antigenic specificities.
|
Int J Cancer
|
1973
|
0.81
|
|
365
|
Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities.
|
J Leukoc Biol
|
1987
|
0.81
|
|
366
|
Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
|
J Natl Cancer Inst
|
1976
|
0.81
|
|
367
|
Effect of influenza A virus infection on natural and adaptive cellular immunity.
|
Clin Immunol Immunopathol
|
1996
|
0.81
|
|
368
|
Acute leukemia in identical twins: search for viral and leukemia-associated antigens.
|
J Natl Cancer Inst
|
1972
|
0.81
|
|
369
|
Conservation of total T-cell counts during HIV infection: alternative hypotheses and implications.
|
J Acquir Immune Defic Syndr Hum Retrovirol
|
1998
|
0.81
|
|
370
|
Cellular immunity to human tumor-associated antigens. A review.
|
Isr J Med Sci
|
1973
|
0.81
|
|
371
|
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
|
Cancer Res
|
1991
|
0.81
|
|
372
|
Induction of protein tyrosine phosphorylation in human natural killer cells by triggering via alpha 4 beta 1 or alpha 5 beta 1 integrins.
|
Blood
|
1995
|
0.81
|
|
373
|
Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes.
|
Proc Natl Acad Sci U S A
|
1987
|
0.81
|
|
374
|
HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
|
Int J Cancer
|
1994
|
0.81
|
|
375
|
Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities.
|
J Natl Cancer Inst
|
1981
|
0.81
|
|
376
|
Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma.
|
Cancer Immunol Immunother
|
1997
|
0.81
|
|
377
|
Inhibition of cell-mediated cytotoxicity against tumor-associated antigens by suppressor cells from tumor-bearing mice.
|
J Natl Cancer Inst
|
1976
|
0.80
|
|
378
|
Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP.
|
J Immunol
|
1982
|
0.80
|
|
379
|
Ligand binding specificities and signal transduction pathways of Fc gamma receptor IIc isoforms: the CD32 isoforms expressed by human NK cells.
|
Eur J Immunol
|
1999
|
0.80
|
|
380
|
Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE.
|
J Immunol
|
1985
|
0.80
|
|
381
|
Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
|
Cancer Res
|
1976
|
0.80
|
|
382
|
Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium.
|
J Reticuloendothel Soc
|
1983
|
0.80
|
|
383
|
Natural killer cells.
|
Hosp Pract (Hosp Ed)
|
1982
|
0.80
|
|
384
|
Cytotoxicity from cultured cells: analysis of precursors involved in generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicity.
|
Cell Immunol
|
1979
|
0.80
|
|
385
|
Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons.
|
J Biol Response Mod
|
1983
|
0.80
|
|
386
|
Production and characterization of supernatants with high titers of human leukocyte inhibitory factor (LIF).
|
J Immunol
|
1980
|
0.80
|
|
387
|
Natural cytotoxic reactivity of rat lymphocytes against gross virus-induced tumor cell lines as measured by [125I]iododeoxyuridine and tritiated proline microcytotoxicity assays.
|
Cancer Res
|
1977
|
0.80
|
|
388
|
Effect of immunoregulatory alpha-globulin on in vitro proliferative response of immune rat lymphocytes to syngeneic Gross virus-induced lymphoma.
|
J Natl Cancer Inst
|
1974
|
0.80
|
|
389
|
Suppression of mixed lymphocyte response in mice bearing primary tumors induced by murine sarcoma virus.
|
Transplantation
|
1976
|
0.80
|
|
390
|
Effects of recombinant interferon-alpha on immune function in cancer patients.
|
J Biol Response Mod
|
1983
|
0.80
|
|
391
|
In vitro tests of cellular immunity in man.
|
Invest Cell Pathol
|
1980
|
0.80
|
|
392
|
Dissociation of multiple polyoma virus functions by ultraviolet irradiation.
|
Proc Soc Exp Biol Med
|
1969
|
0.80
|
|
393
|
Modulation of natural killer cell activity by serum from cancer patients: preliminary results of a study of patients with colorectal adenocarcinoma or other types of cancer.
|
Cancer Res
|
1988
|
0.80
|
|
394
|
Effects of recombinant and hybrid recombinant human leukocyte interferons on cytotoxic activity of natural killer cells.
|
J Biol Chem
|
1983
|
0.80
|
|
395
|
Natural killer cells and their relationship to T-cells: hypothesis on the role of T-cell receptor gene rearrangement on the course of adaptive differentiation.
|
Cancer Res
|
1986
|
0.80
|
|
396
|
Immunomodulation and antitumor effects of MVE-2 in mice.
|
J Biol Response Mod
|
1984
|
0.80
|
|
397
|
Specificity of delayed cutaneous hypersensitivity reactions to extracts of human tumor cells.
|
J Natl Cancer Inst
|
1978
|
0.80
|
|
398
|
Inhibition of activity of human NK and K cells by simple sugars: discrimination between binding and postbinding events.
|
Clin Immunol Immunopathol
|
1984
|
0.79
|
|
399
|
Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients.
|
Int J Cancer
|
1979
|
0.79
|
|
400
|
Reassessment of LAK phenomenology: a review.
|
Nat Immun Cell Growth Regul
|
1987
|
0.79
|
|
401
|
Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations.
|
J Natl Cancer Inst
|
1979
|
0.79
|
|
402
|
Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells.
|
Cell Immunol
|
1989
|
0.79
|
|
403
|
Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
|
J Immunol
|
1988
|
0.79
|
|
404
|
Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man.
|
Cancer Immunol Immunother
|
1989
|
0.79
|
|
405
|
Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates.
|
J Immunother Emphasis Tumor Immunol
|
1996
|
0.79
|
|
406
|
Surface antigens on transplantable tumor cell lines producing mouse type C viruses.
|
J Natl Cancer Inst
|
1977
|
0.79
|
|
407
|
Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission.
|
Blood
|
1989
|
0.79
|
|
408
|
Cellular immunity to tumor-associated antigens of transplantable mammary tumors of C3H/HeN mice.
|
Cancer Res
|
1979
|
0.79
|
|
409
|
Interaction of T cells with allogeneic macrophages in mixed leukocyte cultures in rats.
|
J Immunol
|
1977
|
0.79
|
|
410
|
Evaluation of role of natural killer cells in radiation-induced leukemogenesis in mice.
|
J Natl Cancer Inst
|
1984
|
0.79
|
|
411
|
T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells.
|
Transplant Proc
|
1977
|
0.79
|
|
412
|
Polyribonucleotides for cancer therapy: summary and recommendations for further research.
|
J Biol Response Mod
|
1985
|
0.79
|
|
413
|
Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
|
J Natl Cancer Inst
|
1977
|
0.79
|
|
414
|
Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
|
Int J Cancer
|
1979
|
0.79
|
|
415
|
Demonstration of specific cell-mediated anti-tumor immunity in lung cancer to autologous tissue extracts.
|
Int J Cancer
|
1978
|
0.79
|
|
416
|
Low frequency of NK-cell progenitors and development of suppressor cells in IL-2-dependent cultures of spleen cells from low NK-reactive SJL/J mice.
|
Int J Cancer
|
1986
|
0.79
|
|
417
|
Sensitive and convenient quantitation of antibody binding to cellular antigens using glutaraldehyde preserved cells.
|
J Immunol Methods
|
1979
|
0.79
|
|
418
|
Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer.
|
Int J Cancer
|
1981
|
0.79
|
|
419
|
Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
|
J Immunol Methods
|
2001
|
0.79
|
|
420
|
Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
|
J Immunol
|
1986
|
0.78
|
|
421
|
In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
|
J Immunol
|
1976
|
0.78
|
|
422
|
Skin tests with soluble melanoma antigens in patients with choroidal tumors.
|
Cancer
|
1977
|
0.78
|
|
423
|
Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
|
J Immunol
|
1973
|
0.78
|
|
424
|
Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies: clinical description.
|
Cancer
|
1977
|
0.78
|
|
425
|
Ultraviolet light-induced increase in tumor cell susceptibility to TNF-dependent and TNF-independent natural cell-mediated cytotoxicity.
|
Cell Immunol
|
1991
|
0.78
|
|
426
|
Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity.
|
Cell Immunol
|
1993
|
0.78
|
|
427
|
In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
|
Cancer Res
|
1985
|
0.78
|
|
428
|
Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration.
|
Nat Immun
|
1992
|
0.78
|
|
429
|
Cell-mediated immune responsiveness of patients with acute lymphocytic leukemia in remission.
|
Int J Cancer
|
1976
|
0.78
|
|
430
|
Design of clinical trials with biological response modifiers.
|
Cancer Treat Rep
|
1985
|
0.78
|
|
431
|
Tumor immunology.
|
JAMA
|
1992
|
0.78
|
|
432
|
Lack of expression on cultured human T-lymphocytes of a T-cell antigen shared by the MOLT-4 cell line and normal human thymocytes.
|
In Vitro
|
1980
|
0.78
|
|
433
|
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. II. Purification and identification of rat A-NKP 1 and A-NKP 2 as constituents of the multicatalytic proteinase (proteasome) complex.
|
J Cell Biochem
|
1994
|
0.78
|
|
434
|
Lymphocyte blastogenesis induced by potassium chloride extracts of allogeneic breast carcinoma and lymphoid cells.
|
J Natl Cancer Inst
|
1975
|
0.78
|
|
435
|
Mixed lymphocyte/tumor-cell interaction in a murine sarcoma virus (Moloney)-induced tumor system. Comparison between lymphoproliferation and lymphocyte cytotoxicity.
|
Int J Cancer
|
1976
|
0.78
|
|
436
|
Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth.
|
Concepts Immunopathol
|
1985
|
0.78
|
|
437
|
Nongranular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role.
|
J Immunol
|
1992
|
0.78
|
|
438
|
Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2.
|
In Vivo
|
1994
|
0.78
|
|
439
|
Overnight incubation of mouse spleen cells in recombinant IL-2 generates cytotoxic cells with NK characteristics from precursors enriched with or devoid of LGL.
|
Clin Exp Immunol
|
1989
|
0.78
|
|
440
|
Tumor immunology and immunotherapy.
|
Laryngoscope
|
1977
|
0.78
|
|
441
|
Immunity to antigens associated with a cell line derived from nasopharyngeal cancer (NPC) in non-Chinese NPC patients.
|
Int J Cancer
|
1976
|
0.78
|
|
442
|
In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment.
|
Eur J Cancer
|
1993
|
0.78
|
|
443
|
Possible role of natural killer cells and other effector cells in immune surveillance against cancer.
|
J Invest Dermatol
|
1984
|
0.78
|
|
444
|
Delayed cutaneous hypersensitivity reactions to extracts of human tumors.
|
Natl Cancer Inst Monogr
|
1973
|
0.78
|
|
445
|
Involvement of the 2'-5' A pathway in the augmentation of natural killer activity.
|
Nat Immun Cell Growth Regul
|
1987
|
0.78
|
|
446
|
Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
|
Nat Immun Cell Growth Regul
|
1985
|
0.77
|
|
447
|
Generation of natural killer cells from long-term cultures of mouse bone marrow.
|
Nat Immun
|
1993
|
0.77
|
|
448
|
Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
|
J Natl Cancer Inst
|
1979
|
0.77
|
|
449
|
Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies. II. Chromosomal and immunologic abnormalities.
|
Cancer
|
1977
|
0.77
|
|
450
|
Immunologic abnormalities in melanoma-prone families.
|
J Natl Cancer Inst
|
1979
|
0.77
|
|
451
|
Inhibition of the activity of mouse natural killer cells by urethan.
|
J Natl Cancer Inst
|
1981
|
0.77
|
|
452
|
Systemic and in situ natural killer activity in transplanted and spontaneous mammary tumors in C3H/HeN mice.
|
J Reticuloendothel Soc
|
1981
|
0.77
|
|
453
|
Systemic and in situ natural killer activity in C57BL/6N and CBA/N mice bearing murine sarcoma virus-induced regressor tumors.
|
J Natl Cancer Inst
|
1980
|
0.77
|
|
454
|
Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
|
J Immunol
|
1976
|
0.77
|
|
455
|
Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity.
|
Cell Immunol
|
1990
|
0.77
|
|
456
|
Participation of three lymphoid cell types in the in vitro activation of cell-mediated immunity to a syngeneic gross virus-induced lymphoma in rats.
|
Cell Immunol
|
1976
|
0.77
|
|
457
|
Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group.
|
Leuk Lymphoma
|
1999
|
0.77
|
|
458
|
Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
|
J Immunol
|
1977
|
0.77
|
|
459
|
Effect of various cytokines and growth factors on the interleukin-2-dependent in vitro differentiation of natural killer cells from bone marrow.
|
Nat Immun Cell Growth Regul
|
1989
|
0.77
|
|
460
|
Augmentation of antileukemia lytic activity by OKT3 monoclonal antibody: synergism of OKT3 and interleukin-2.
|
Nat Immun Cell Growth Regul
|
1987
|
0.77
|
|
461
|
In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity.
|
J Immunol
|
1976
|
0.77
|
|
462
|
Cytotoxicity against tumour-associated antigens not H-2 restricted.
|
Nature
|
1977
|
0.77
|
|
463
|
Relationship of human natural lymphocyte-mediated cytotoxicity to cytotoxicity of breast-cancer-derived target cells.
|
Int J Cancer
|
1977
|
0.77
|
|
464
|
Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
|
Arch Otolaryngol Head Neck Surg
|
1995
|
0.77
|
|
465
|
Natural killer cells and tumor immunity.
|
Year Immunol
|
1990
|
0.77
|
|
466
|
Studies on the mechanism of low natural killer cell activity in infant and aged mice.
|
Nat Immun Cell Growth Regul
|
1986
|
0.77
|
|
467
|
Low natural killer syndrome: clinical and immunologic features.
|
Nat Immun Cell Growth Regul
|
1987
|
0.77
|
|
468
|
Suppression of natural killer (NK) activity by splenic adherent cells of low NK-reactive mice.
|
Int J Cancer
|
1981
|
0.77
|
|
469
|
Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens.
|
J Natl Cancer Inst
|
1977
|
0.77
|
|
470
|
Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow.
|
J Immunol
|
1994
|
0.77
|
|
471
|
Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas.
|
Cancer Res
|
1974
|
0.77
|
|
472
|
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets.
|
Cancer Immunol Immunother
|
1987
|
0.77
|
|
473
|
Augmentation of human natural killer cell activity by interferon: conditions required for boosting and characteristics of the effector cells.
|
J Interferon Res
|
1981
|
0.77
|
|
474
|
The effect of specific anti-rat thymocyte serum on cell-mediated tumor immunity and other lymphocyte functions.
|
Cell Immunol
|
1974
|
0.77
|
|
475
|
In vitro inhibition of cell-mediated cytotoxicity against syngeneic Friend virus-induced leukemia by immunoregulatory alpha globulin.
|
J Natl Cancer Inst
|
1975
|
0.77
|
|
476
|
Natural killer cells and tumor immunity.
|
Surv Immunol Res
|
1983
|
0.77
|
|
477
|
Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
|
J Immunol
|
1979
|
0.77
|
|
478
|
Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2.
|
J Immunol
|
1978
|
0.77
|
|
479
|
Regulation of human natural cytotoxicity by IgG. II. Cyclic AMP as a mediator of monomeric IgG-induced inhibition of natural killer cell activity.
|
Cell Immunol
|
1988
|
0.77
|
|
480
|
Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
|
Br J Cancer
|
1992
|
0.77
|
|
481
|
Potential role of natural antibodies in resistance to tumor growth.
|
Nat Immun
|
1995
|
0.77
|
|
482
|
Augmentation of natural killer activity by pyran copolymer in mice.
|
Int J Cancer
|
1979
|
0.77
|
|
483
|
Heterogeneity of surface antigens on endogenous type C virus-producing cell sublines derived from a clonal line of BALB/3T3 cells.
|
Intervirology
|
1975
|
0.77
|
|
484
|
Effects of biological response modifiers on effector cells with cytotoxic activity against tumors.
|
Semin Oncol
|
1986
|
0.77
|
|
485
|
Mechanism of tumor cell lysis by natural killer cells.
|
Adv Exp Med Biol
|
1982
|
0.77
|
|
486
|
Interferon and natural killer (NK) cells.
|
Tex Rep Biol Med
|
1983
|
0.77
|
|
487
|
Therapy of peritoneal murine cancer with biological response modifiers.
|
J Immunopharmacol
|
1985
|
0.77
|
|
488
|
Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.
|
J Immunother (1991)
|
1991
|
0.77
|
|
489
|
Differential in vitro modulation of suppressor and antitumor functions of mouse macrophages by lymphokines and/or endotoxin.
|
Cell Immunol
|
1988
|
0.76
|
|
490
|
Proliferative effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) and calcium ionophores on human large granular lymphocytes (LGL).
|
Cell Immunol
|
1988
|
0.76
|
|
491
|
Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies.
|
Nat Immun
|
1995
|
0.76
|
|
492
|
Summary: potential of interleukin-2 for the therapy of cancer.
|
J Biol Response Mod
|
1984
|
0.76
|
|
493
|
Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
|
Cancer Res
|
1985
|
0.76
|
|
494
|
Effect of UV light on tumor cell sensitivity to NK and NC cell-mediated lysis.
|
Nat Immun
|
1994
|
0.76
|
|
495
|
In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
|
Cancer Res
|
1979
|
0.76
|
|
496
|
Delayed hypersensitivity skin reactions to antigens on human tumors.
|
Cancer
|
1974
|
0.76
|
|
497
|
Cancer therapy by biological response modifiers.
|
Clin Physiol Biochem
|
1987
|
0.76
|
|
498
|
Overview on NK cells and possible mechanisms for their cytotoxic activity.
|
Adv Exp Med Biol
|
1982
|
0.76
|
|
499
|
Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
|
J Natl Cancer Inst
|
1977
|
0.76
|
|
500
|
The biology of human natural killer cells.
|
Ann Ist Super Sanita
|
1990
|
0.76
|
|
501
|
Occult (non-surface expression) of T, B and monocyte markers in human large granular lymphocytes.
|
Mol Immunol
|
1987
|
0.76
|
|
502
|
Depression of natural antitumor resistance of C57BL/6 mice by leukemogenic doses of radiation and restoration of resistance by transfer of bone marrow or spleen cells from normal, but not beige, syngeneic mice.
|
J Natl Cancer Inst
|
1982
|
0.76
|
|
503
|
Protection of penetrating corneal allografts from immune rejection.
|
Am J Ophthalmol
|
1972
|
0.76
|
|
504
|
Assay of augmentation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity by interferon.
|
Methods Enzymol
|
1981
|
0.76
|
|
505
|
Expression of Fc mu receptors on human natural killer cells.
|
Clin Immunol Immunopathol
|
1991
|
0.76
|
|
506
|
Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive transfer.
|
Cancer Res
|
1996
|
0.76
|
|
507
|
Use of activated natural killer cells for tumor immunotherapy in mouse and human.
|
Methods Mol Biol
|
2000
|
0.75
|
|
508
|
Persistently low natural killer cell activity and circulating levels of plasma beta endorphin: risk factors for infectious disease.
|
Life Sci
|
1991
|
0.75
|
|
509
|
Rationale for recombinant human interferon-gamma adjuvant immunotherapy for cancer.
|
J Natl Cancer Inst
|
1988
|
0.75
|
|
510
|
Neural modulation of immunity: conditioning phenomena and the adaptability of lymphoid cells.
|
Int J Neurosci
|
1994
|
0.75
|
|
511
|
Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors.
|
Hepatology
|
1989
|
0.75
|
|
512
|
Degradation of enkephalins by rat lymphocyte and purified rat natural killer cell surface aminopeptidases.
|
Brain Behav Immun
|
1993
|
0.75
|
|
513
|
"High-affinity" T-cell rosettes: the effects of clinical manipulations and potential prognostic significance.
|
J Surg Oncol
|
1980
|
0.75
|
|
514
|
Inhibition of growth of mouse leukemic cell lines in vitro and in vivo by a monoclonal antibody that recognizes an interleukin 3 receptor-associated protein.
|
Cancer Res
|
1991
|
0.75
|
|
515
|
Interleukin-1 augments the interleukin-2-dependent generation of natural killer cells from bone marrow precursors.
|
Nat Immun Cell Growth Regul
|
1987
|
0.75
|
|
516
|
Radioisotope assay for evaluation of in vivo natural cell-mediated resistance of mice to local transplantation of tumor cells.
|
Int J Cancer
|
1981
|
0.75
|
|
517
|
In vitro correlates of cell-mediated immunity to experimental and human leukemia.
|
Bibl Haematol
|
1975
|
0.75
|
|
518
|
Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumors.
|
Cancer Immunol Immunother
|
1989
|
0.75
|
|
519
|
Cellular immune reactions in human acute leukemia.
|
Hamatol Bluttransfus
|
1974
|
0.75
|
|
520
|
Can NK cells play a role in therapy of leukemia?
|
Nat Immun Cell Growth Regul
|
1986
|
0.75
|
|
521
|
Characterization of Corynebacterium parvum-induced suppressor cells of mouse NK and ADCC activity.
|
Immunopharmacol Immunotoxicol
|
1990
|
0.75
|
|
522
|
Immunologic reactivity of lymphoid cells in tumors.
|
Contemp Top Immunobiol
|
1980
|
0.75
|
|
523
|
Immunologically defined prognostic subgroups as predictors of response to BCG immunotherapy.
|
Recent Results Cancer Res
|
1982
|
0.75
|
|
524
|
In vivo effects of cytokines on development of natural killer cells and antitumor activity in lethally irradiated bone marrow transplanted recipients.
|
J Biol Response Mod
|
1990
|
0.75
|
|
525
|
Identification and characterization: cell membrane antigens associated with the blast phase of human adult leukemia.
|
Bibl Haematol
|
1975
|
0.75
|
|
526
|
Detection of liver metastases with 5'-nucleotide phosphodiesterase isozyme-V in gastrointestinal cancer patients.
|
Oncology
|
1980
|
0.75
|
|
527
|
Rat natural killer cell activity against lymphoid and nonlymphoid tumor cells and normal rat cell lines.
|
Cancer Res
|
1983
|
0.75
|
|
528
|
High incidence of migration inhibition reactivity to lung tumor-associated antigen by normal donors in close contact with lung cancer patients or materials.
|
J Natl Cancer Inst
|
1980
|
0.75
|
|
529
|
Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
|
Prog Clin Biol Res
|
1987
|
0.75
|
|
530
|
Biological response modifiers for the therapy of cancer.
|
Ann Allergy
|
1985
|
0.75
|
|
531
|
Serologic analysis of the antigenic specificities of simian virus 40-transformed cells and their relationship to tumor-associated transplantation antigen.
|
J Natl Cancer Inst
|
1974
|
0.75
|
|
532
|
Tumor immunology and its application to the diagnosis of cancer.
|
Ann Clin Lab Sci
|
1974
|
0.75
|
|
533
|
Characterization of cell lines enhancing IL-2 production by human phytohemagglutinin-stimulated lymphocytes.
|
Cell Immunol
|
1985
|
0.75
|
|
534
|
Separation of the major histocompatibility antigens from other antigens present on human leukemic and white blood cell membranes.
|
Bibl Haematol
|
1973
|
0.75
|
|
535
|
Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.
|
J Clin Oncol
|
1985
|
0.75
|
|
536
|
The human interferons: from the past and into the future.
|
Symp Fundam Cancer Res
|
1984
|
0.75
|
|
537
|
Effect of interleukin-2 on the monomeric IgG-induced inhibition of human natural killer cell activity.
|
Nat Immun Cell Growth Regul
|
1989
|
0.75
|
|
538
|
Expression of murine CD34 by fetal liver NK cell progenitors.
|
Exp Hematol
|
1999
|
0.75
|
|
539
|
Cytolytic effects of alloantiserum in patients with lymphoproliferative disorders.
|
Cancer
|
1971
|
0.75
|
|
540
|
Variation among mouse strains in responsiveness to migration inhibitory factor.
|
Cell Immunol
|
1979
|
0.75
|
|
541
|
Natural killer cell precursors in the CD44neg/dim T-cell receptor population of mouse bone marrow.
|
Blood
|
1996
|
0.75
|
|
542
|
Effect of heparin on the detection of human isoantigens by the cytotoxicity technique.
|
Nature
|
1970
|
0.75
|
|
543
|
Counterpoint: animal tumor models and their relevance to human tumor immunology.
|
J Biol Response Mod
|
1983
|
0.75
|
|
544
|
Cellular cytotoxicity reactions to human leukemia associated antigens.
|
Bibl Haematol
|
1973
|
0.75
|
|
545
|
Regulation of human natural cytotoxicity by IgG. III. Interaction between negative regulation by monomeric IgG and positive regulation by interferons of different types.
|
Nat Immun Cell Growth Regul
|
1989
|
0.75
|
|
546
|
Cell-mediated cytotoxic reactions to tumor associated antigens.
|
J Reticuloendothel Soc
|
1975
|
0.75
|
|
547
|
NK cells and tumor immunity: 1983.
|
Surv Immunol Res
|
1984
|
0.75
|
|
548
|
Two mechanisms of migration inhibition factor induction by tumour antigens.
|
Nature
|
1977
|
0.75
|
|
549
|
Role of interferons in natural killer cell generation from primitive bone marrow precursors.
|
Int J Immunopharmacol
|
1988
|
0.75
|
|
550
|
Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
|
J Immunol
|
1990
|
0.75
|
|
551
|
Immunodiagnostics for cancer testing. A look at the future.
|
Antibiot Chemother (1971)
|
1979
|
0.75
|
|
552
|
Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes.
|
Immunol Ser
|
1989
|
0.75
|
|
553
|
Adriamycin-induced antitumor response in lethally irradiated mice.
|
Immunopharmacology
|
1979
|
0.75
|
|
554
|
Leukemia antigens and immunity in man.
|
Haematologia (Budap)
|
1983
|
0.75
|
|
555
|
Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas.
|
J Natl Cancer Inst
|
1977
|
0.75
|
|
556
|
Surface aminopeptidase activity of rat natural killer cells. I. Biochemical and biological properties.
|
Biochim Biophys Acta
|
1994
|
0.75
|
|
557
|
Natural killer cells and tumor immunity: 1985.
|
Year Immunol
|
1986
|
0.75
|
|
558
|
Immune responses to virus induced experimental leukemia and to human leukemia.
|
Johns Hopkins Med J Suppl
|
1974
|
0.75
|
|
559
|
The effect of non-specific immune stimulation on corneal allograft survival in rabbits.
|
Can J Ophthalmol
|
1974
|
0.75
|
|
560
|
Evaluation of a complement-dependent human cytotoxic antibody reactive with Burkitt's lymphoma biopsy cells.
|
Proc Soc Exp Biol Med
|
1970
|
0.75
|
|
561
|
Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
|
Cell Immunol
|
1995
|
0.75
|
|
562
|
Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas.
|
J Natl Cancer Inst
|
1978
|
0.75
|
|
563
|
Cancer-associated serum globulin demonstrated by polyacrylamide gel electrophoresis.
|
J Natl Cancer Inst
|
1980
|
0.75
|
|
564
|
Chemoimmunotherapy of metastatic murine renal cell carcinoma using flavone acetic acid and interleukin 2.
|
J Urol
|
1992
|
0.75
|
|
565
|
Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.
|
Clin Exp Metastasis
|
1985
|
0.75
|
|
566
|
Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells.
|
In Vivo
|
1994
|
0.75
|
|
567
|
Natural killer cell cytolytic granule-associated enzymes. I. Purification, characterization, and analysis of function of an enzyme with sulfatase activity.
|
J Immunol
|
1991
|
0.75
|
|
568
|
Up-regulation of natural killer activity of human immunodeficiency virus-infected patients by in vitro-differentiated macrophages.
|
Clin Immunol Immunopathol
|
1989
|
0.75
|
|
569
|
Prolactin receptor expression by rat NK cells.
|
Nat Immun
|
1995
|
0.75
|
|
570
|
In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells.
|
Immunopharmacology
|
1989
|
0.75
|
|
571
|
Inhibition of NK cell generation by Corynebacterium parvum.
|
Immunopharmacol Immunotoxicol
|
1991
|
0.75
|
|
572
|
Simplified technique for the T-globulin cancer test.
|
J Natl Cancer Inst
|
1973
|
0.75
|
|
573
|
Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen.
|
J Natl Cancer Inst
|
1978
|
0.75
|
|
574
|
Sequential metabolic events and morphological changes during in vivo large granular lymphocyte activation and proliferation.
|
Cell Immunol
|
1986
|
0.75
|
|
575
|
Immunological control of breast cancer: discussion.
|
Cancer Res
|
1976
|
0.75
|
|
576
|
Specific afferent interference by antiserum of in vivo immunity.
|
Nature
|
1975
|
0.75
|
|
577
|
Overview and perspectives: natural resistance mechanisms.
|
Adv Exp Med Biol
|
1982
|
0.75
|
|
578
|
The effect of acute and chronic leukapheresis on the natural killer (NK) cell function of normal human volunteers.
|
Am J Hematol
|
1986
|
0.75
|
|
579
|
Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin.
|
J Immunol
|
1976
|
0.75
|
|
580
|
Immunologic monitoring in carcinoma of the breast.
|
Surg Gynecol Obstet
|
1977
|
0.75
|
|
581
|
Cytophilic immunoglobulins revisited via natural killer cells.
|
FASEB J
|
1996
|
0.75
|
|
582
|
Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens.
|
Ann Immunol (Paris)
|
1973
|
0.75
|
|
583
|
Lymphokine-activated killer cells: analysis of their anti-tumour efficacy in vitro and in vivo.
|
Ann Inst Pasteur Immunol
|
1988
|
0.75
|
|
584
|
Assessment of biological responses: what to measure and when.
|
Cancer Treat Rep
|
1985
|
0.75
|
|
585
|
Specificity of cellular immune reactivity to virus-induced tumours.
|
Nat New Biol
|
1972
|
0.75
|
|
586
|
Inhibition of human natural killer cell activity by polyclonal IgM.
|
Mol Immunol
|
1989
|
0.75
|
|
587
|
Immunological study of two stocks of Moloney sarcoma virus producing regressor and progressor tumors in C57BL/6 mice.
|
Int J Cancer
|
1978
|
0.75
|
|
588
|
The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
|
Cell Immunol
|
1990
|
0.75
|
|
589
|
Interferon-independent, lectin-induced augmentation of murine natural killer cell activity.
|
Int J Cancer
|
1982
|
0.75
|
|
590
|
Letter: Tumor-associated antigen in female and male breast cancer.
|
N Engl J Med
|
1975
|
0.75
|
|
591
|
Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
|
IARC Sci Publ
|
1975
|
0.75
|
|
592
|
Selective augmentation by recombinant interferon-gamma of the intracellular content of S-adenosylmethionine in murine macrophages.
|
J Immunol
|
1986
|
0.75
|
|
593
|
Lymphocyte-mediated cytotoxicity.
|
Pediatr Ann
|
1987
|
0.75
|
|
594
|
NK cells and tumor immunity: 1984.
|
Year Immunol
|
1985
|
0.75
|
|
595
|
Lack of specificity of lymphocyte-mediated cytotoxicity against the bladder cancer cell line, T24.
|
J Urol
|
1977
|
0.75
|
|
596
|
Effect of various immunoregulatory substances on the growth inhibitory activity (GIA) of human monocytes against lymphoblastoid cell lines.
|
Immunopharmacology
|
1982
|
0.75
|
|
597
|
Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat.
|
Blood
|
1991
|
0.75
|
|
598
|
Natural killer cells in lungs and other tissues and regulation of their activity by suppressor cells.
|
J Allergy Clin Immunol
|
1986
|
0.75
|
|
599
|
New immunologic markers for monitoring of cancer.
|
Ann Chir Gynaecol
|
1989
|
0.75
|
|
600
|
Prolonged survival of a rabbit skin allograft following corneal transplantation from the same donor.
|
Ann Ophthalmol
|
1973
|
0.75
|
|
601
|
Kinetics of the response of different classes of antibodies to skin allografts in mice.
|
Transplantation
|
1971
|
0.75
|
|
602
|
Suppression of T-cell mediated lymphokine production but not cytotoxic activity by macrophages.
|
Boll Ist Sieroter Milan
|
1980
|
0.75
|
|
603
|
Cellular immune reactions to human leukemia.
|
Natl Cancer Inst Monogr
|
1972
|
0.75
|
|
604
|
Cytotoxic antibody reactive with cultures of lymphoid cells: occurrence in disease and normal human sera.
|
J Natl Cancer Inst
|
1971
|
0.75
|
|
605
|
Cloned lines of SJL/J spleen cells with cytotoxic reactivity.
|
Int J Cancer
|
1983
|
0.75
|
|
606
|
In vitro effects of an acyltripeptide, FK565, on antitumor effector activities and on metabolic activities of human monocytes and granulocytes.
|
Immunopharmacology
|
1990
|
0.75
|
|
607
|
In vivo and in vitro assays of cellular immunity to human tumor antigens.
|
Fed Proc
|
1973
|
0.75
|
|
608
|
Immunochemical characterization of tumor-associated surface antigens on a Moloney leukemia virus-lymphoma, MBL-2.
|
Int J Cancer
|
1979
|
0.75
|
|
609
|
Letter: Heparin and T-cell rosettes.
|
N Engl J Med
|
1976
|
0.75
|
|
610
|
Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients.
|
J Natl Cancer Inst
|
1981
|
0.75
|
|
611
|
Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction.
|
Cancer Res
|
1974
|
0.75
|
|
612
|
Cell-mediated cytotoxicity against human tumors: lessons learned and future prospects.
|
J Biol Response Mod
|
1983
|
0.75
|
|
613
|
Activation of natural killer (NK) cells and mechanism of their cytotoxic effects.
|
Adv Exp Med Biol
|
1987
|
0.75
|
|
614
|
51Cr-labeled human hepatocytes as target cells for cytotoxicity mediated by freshly isolated liver-infiltrating lymphocytes.
|
J Immunol Methods
|
1993
|
0.75
|
|
615
|
Cancer therapy by biological response modifiers.
|
Arzneimittelforschung
|
1987
|
0.75
|
|
616
|
Changes in immune function in patients receiving natural leukocyte interferon.
|
J Biol Response Mod
|
1983
|
0.75
|
|
617
|
Acute myelomonocytic leukemia associated with paraproteinemia.
|
Cancer
|
1976
|
0.75
|
|
618
|
Psychoneuroimmunology and cancer: fifteenth Sapporo Cancer Seminar.
|
Cancer Res
|
1996
|
0.75
|
|
619
|
Immune recognition of tumor cells in vivo. I. Role of H-2 gene products in T lymphocyte activation against minor histocompatibility antigens displayed by adenocarcinoma cells.
|
Eur J Immunol
|
1982
|
0.75
|
|
620
|
Cell-mediated immunity to leukemia associated antigens in experimental models and in man.
|
Hamatol Bluttransfus
|
1976
|
0.75
|
|
621
|
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity.
|
Clin Exp Metastasis
|
1987
|
0.75
|
|
622
|
Immunization by irradiated whole cells or cell extracts against an experimental bladder tumor.
|
Invest Urol
|
1980
|
0.75
|
|
623
|
Serum factors in renal carcinoma.
|
Lancet
|
1971
|
0.75
|
|
624
|
Alterations in cell-surface carbohydrates of rat large granular lymphocytes associated with interleukin-2 activation.
|
Cell Immunol
|
1990
|
0.75
|
|
625
|
Serum and tissue banks for biological markers.
|
Immunol Ser
|
1990
|
0.75
|
|
626
|
Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors.
|
Int J Cancer
|
1979
|
0.75
|
|
627
|
Partially restorative role of T cells for low interleukin 2 dependent growth of NK cell progenitors from nude mice.
|
Nat Immun Cell Growth Regul
|
1984
|
0.75
|
|
628
|
Mouse strain-related differences in the biologic and immunologic responses to a murine sarcoma virus.
|
J Natl Cancer Inst
|
1973
|
0.75
|
|
629
|
Nucleases and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice.
|
J Natl Cancer Inst
|
1978
|
0.75
|
|
630
|
Species-restricted effects of human and mouse lymphokines on macrophages.
|
Eur J Immunol
|
1980
|
0.75
|
|
631
|
Overview on new immunologic markers for diagnosis of cancer.
|
Cancer
|
1978
|
0.75
|
|
632
|
Assessment of cellular immune response to cancer of the breast.
|
Ann Clin Lab Sci
|
1980
|
0.75
|
|
633
|
Anti-Ly-6E.1-monoclonal-antibody-mediated augmentation of interleukin-2-dependent generation of natural killer cell activity from mouse bone marrow cells.
|
Nat Immun
|
1995
|
0.75
|
|
634
|
Up-regulation of tumor cell sensitivity to natural cell-mediated cytotoxicity by UV light irradiation.
|
Immunol Ser
|
1994
|
0.75
|
|
635
|
Cytostasis of tumor cell lines by granulocytes from cancer patients and normal human donors.
|
Int J Cancer
|
1981
|
0.75
|
|
636
|
Treatment of canine transmissible venereal tumor by intravenous administration of protein A.
|
J Biol Response Mod
|
1984
|
0.75
|
|
637
|
Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
|
J Natl Cancer Inst
|
1984
|
0.75
|
|
638
|
The use of 5-fluorouracil to enhance natural killer activity in rat bone marrow.
|
Transplant Proc
|
1989
|
0.75
|
|
639
|
Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
|
Surg Forum
|
1975
|
0.75
|
|
640
|
Cell-mediated immunity in human acute leukemia.
|
Bibl Haematol
|
1975
|
0.75
|
|
641
|
Natural killer cells and tumor immunity: 1987.
|
Year Immunol
|
1989
|
0.75
|
|
642
|
Immunotherapy in previously treated acute lymphatic leukemia.
|
Natl Cancer Inst Monogr
|
1973
|
0.75
|
|
643
|
Second counterpoint: animal tumor models and their relevance to human tumor immunology.
|
J Biol Response Mod
|
1983
|
0.75
|
|
644
|
Natural killer (NK) cells.
|
Prog Clin Biol Res
|
1981
|
0.75
|
|
645
|
A trial of autologous plasma perfusion over protein A in patients with breast cancer.
|
J Biol Response Mod
|
1984
|
0.75
|
|
646
|
Solubilization of G (gross) antigens on the surface of G leukemia cells.
|
J Natl Cancer Inst
|
1973
|
0.75
|